What Does Research Say About IFS Therapy?
Internal Family Systems, or IFS, is everywhere.
Therapists talk about:
parts,
protectors,
exiles,
Self,
and the idea that seemingly contradictory reactions may make much more sense when we understand what each part is trying to do.
Clients often find the language intuitive.
Instead of:
“Why am I sabotaging myself?”
IFS might ask:
“What is this part trying to protect?”
Instead of:
“Why can’t I just get over this?”
IFS might ask:
“What does the part holding this pain need?”
That conceptual shift can be powerful.
But popularity is not the same thing as evidence.
So what does the research actually say?
First: what is Internal Family Systems?
IFS was developed by Richard Schwartz.
The model proposes that the mind naturally contains multiple internal “parts,” each with its own emotions, beliefs, roles, and protective strategies.
A person may have:
a perfectionistic part,
a highly responsible part,
a critical part,
a people-pleasing part,
a part that wants closeness,
a part that distrusts everyone,
a part that wants to move forward,
and another part that is terrified of doing so.
IFS does not treat this internal multiplicity as inherently pathological.
Instead, the model assumes that many parts developed adaptive roles in response to experience.
What is “Self” in IFS?
IFS also proposes the idea of Self.
Self is generally described as a centered state associated with qualities such as:
curiosity,
compassion,
clarity,
calm,
confidence,
courage,
creativity,
and connectedness.
The therapeutic goal is not to eliminate parts.
It is to help parts become less extreme and develop a different relationship with Self and with one another.
Why has IFS become so popular?
One reason is that the model often feels immediately understandable.
People commonly experience internal conflict.
“I want to leave, but part of me wants to stay.”
“I know I’m safe, but another part of me is terrified.”
“I want intimacy, but I also want everyone to leave me alone.”
“I know this wasn’t my fault, but part of me still believes it was.”
IFS gives language to those contradictions without automatically treating one side as irrational.
That can reduce shame.
But is IFS evidence-based?
This is where precision matters.
IFS has an emerging evidence base.
It has been studied in randomized trials.
There are promising findings.
But the research literature remains substantially smaller than the evidence supporting established PTSD treatments such as EMDR, Cognitive Processing Therapy, and Prolonged Exposure.
Even the IFS Institute currently describes the evidence base as emerging and states that more well-designed randomized controlled trials and replication are needed before condition-specific efficacy can be firmly established.
That is a useful and appropriately cautious description.
What has IFS been studied for?
Published research has examined IFS in populations including people experiencing:
depression,
rheumatoid arthritis and associated psychological distress,
PTSD,
and trauma-related symptoms.
There are also studies examining outcomes such as:
self-compassion,
emotion regulation,
pain,
and psychological functioning.
The number of high-quality trials remains relatively small.
What does the depression research show?
One randomized pilot study examined IFS for depression among 37 female college students.
Participants were randomly assigned to IFS or treatment as usual consisting of CBT or interpersonal psychotherapy.
Depressive symptoms declined in both groups.
The researchers did not find a significant difference in the rate or magnitude of improvement between IFS and the comparison treatments.
That is encouraging in one sense.
IFS appeared capable of producing improvement comparable to established therapies in this small pilot.
But the study was tiny.
It should not be treated as proof that IFS is equivalent to CBT or interpersonal psychotherapy across broader populations.
What about IFS and chronic illness?
A randomized proof-of-concept study evaluated an IFS-based intervention among 79 adults with rheumatoid arthritis.
Participants were randomized to either an IFS intervention or an education control condition.
The study found post-treatment improvements favoring IFS in overall pain and physical functioning.
At one-year follow-up, improvements favoring IFS remained in:
self-reported joint pain,
self-compassion,
and depressive symptoms.
However, there were not sustained improvements in anxiety, self-efficacy, or objective rheumatoid arthritis disease activity.
Again:
interesting.
Promising.
But not evidence that IFS treats rheumatoid arthritis itself.
The intervention appeared to affect some psychological and subjective health outcomes—not the underlying disease activity.
What about IFS for PTSD?
This is where the evidence has recently become more interesting.
Researchers developed an IFS-based program called PARTS, or Program for Alleviating and Resolving Trauma and Stress.
It combines:
16 weekly online group sessions
with
eight individual counseling sessions.
A 2024 proof-of-concept study found the program feasible and acceptable and reported improvements in PTSD and related symptoms.
But proof-of-concept research cannot establish whether the treatment itself caused the changes.
For that, randomized trials matter.
A randomized PTSD trial was published in 2026
In January 2026, researchers published a randomized controlled trial comparing PARTS with an active control intervention called Nature-Based Stress Reduction for Trauma Survivors.
The study included 60 participants with PTSD.
Thirty received PARTS.
Thirty received the comparison intervention.
Both programs included substantial group treatment.
The researchers measured PTSD symptoms using the clinician-administered CAPS-5, one of the standard research instruments used to evaluate PTSD severity.
What happened?
Both groups improved significantly.
Participants receiving PARTS attended more group sessions and reported greater group satisfaction.
But on the primary PTSD outcome, there was no statistically significant difference between PARTS and the active control treatment.
That is extremely important.
It means the trial showed that the IFS-based treatment was:
feasible,
acceptable,
engaging,
and associated with PTSD symptom improvement.
But it did not establish that IFS produced greater PTSD symptom reduction than the well-matched comparison condition.
Is that a negative result?
Not exactly.
It depends on the question.
If the question is:
“Can an IFS-based PTSD program be delivered successfully and do people improve while receiving it?”
The answer from this study is encouraging.
If the question is:
“Has this trial demonstrated that IFS is specifically efficacious for PTSD beyond a credible active treatment?”
The answer is no.
That distinction is essential.
Why active control groups matter
Imagine studying a therapy against a waitlist.
One group receives:
attention,
support,
structure,
expectation of improvement,
regular appointments,
and therapeutic interaction.
The other group receives nothing yet.
If the therapy group improves more, we still do not know how much of the benefit came from the specific therapy versus receiving substantial care.
An active control gives the comparison group a meaningful intervention too.
That makes it harder for the experimental therapy to “win.”
But it also produces stronger science.
The 2026 trial is actually useful because of that
The PARTS trial does not give us the dramatic headline:
“IFS beats another PTSD treatment.”
Instead, it gives us something more clinically useful.
IFS-based group treatment appears feasible.
People were willing to participate.
Satisfaction was high.
PTSD symptoms improved.
But we still need larger randomized trials to determine how much of that improvement is specifically attributable to IFS.
That is where the evidence currently stands.
What does the IFS Institute say about its own research?
Interestingly, the IFS Institute itself now describes the evidence base cautiously.
Its research overview states that current evidence is limited in scope and that well-designed randomized trials with replication are still needed for specific mental health conditions.
It also notes that, to date, depression is the mental health condition for which statistically significant improvement has been demonstrated across multiple pilot randomized trials.
That is considerably more precise than some claims about IFS found online.
So is IFS an evidence-based PTSD treatment?
I would not put it in the same evidence category as EMDR, CPT, or Prolonged Exposure at this point.
Those treatments have:
many randomized trials,
larger evidence bases,
multiple independent research groups,
meta-analyses,
and inclusion in major PTSD treatment guidelines.
IFS does not yet have that depth of evidence.
It has promising early PTSD research.
That is different.
Promising does not mean ineffective
This is worth emphasizing.
A small evidence base does not mean a therapy does not work.
It means we have less certainty.
There are many reasons a psychotherapy can have limited research:
it may be newer,
less heavily funded,
harder to manualize,
or simply earlier in its research lifecycle.
The appropriate response is neither:
“IFS is proven.”
nor:
“IFS is unsupported.”
The more accurate statement is:
IFS has an emerging empirical foundation that needs considerably more rigorous replication.
Why therapists should care about this distinction
Because language matters.
If we tell clients:
“IFS is scientifically proven to treat trauma,”
we are overstating the evidence.
If we tell them:
“There is no research on IFS,”
that is also no longer accurate.
The truth sits between those claims.
There are randomized studies.
There is emerging PTSD research.
There are encouraging results in depression and some other outcomes.
But the evidence is still developing.
How does IFS compare with EMDR research?
The difference in research maturity is substantial.
EMDR has been studied for decades.
It is recommended in major PTSD treatment guidelines.
It has been evaluated across numerous randomized trials and meta-analyses.
IFS has far fewer randomized studies and much less replication.
That does not mean IFS cannot be clinically valuable.
It means the evidence claims should be different.
How does IFS compare with CPT or Prolonged Exposure?
The same principle applies.
Cognitive Processing Therapy and Prolonged Exposure have extensive PTSD evidence.
IFS currently does not have equivalent research depth.
A clinician can still integrate IFS thoughtfully.
But integration should not erase the differences in evidence.
Does therapy have to be a competition?
No.
This is where modality debates often become unhelpful.
A client may benefit from:
IFS for understanding protectors,
ART for a specific intrusive image,
EMDR for associative memory processing,
CPT for trauma-related beliefs,
or another intervention for another problem.
The question does not need to be:
“Which therapy is the winner?”
It can be:
“What is this intervention especially useful for in this particular client?”
What IFS may offer clinically even while research develops
IFS can provide a very useful framework for understanding internal conflict.
Consider someone who says:
“I desperately want a relationship, but the moment someone gets close, I want to leave.”
A purely cognitive interpretation might focus on irrational thinking.
IFS might ask:
What does the withdrawing part expect will happen?
What is it protecting?
What previous experience taught it that closeness is dangerous?
That can open a different kind of clinical conversation.
IFS can reduce the war with yourself
One of the most useful aspects of parts work is that it can shift the question from:
“How do I get rid of this reaction?”
to:
“Why is this reaction here?”
That can be especially important with:
perfectionism,
people-pleasing,
hypervigilance,
avoidance,
self-criticism,
emotional shutdown,
and control.
Many of those behaviors developed because they solved a problem at some point.
Protectors make sense in context
A critical part may believe criticism keeps you from making mistakes.
A people-pleasing part may believe keeping everyone happy prevents abandonment.
A controlling part may believe uncertainty is dangerous.
A part that never asks for help may believe dependence leads to disappointment.
A shutdown part may believe feeling nothing is safer than being overwhelmed.
Understanding the protective logic does not mean the strategy still works.
But it can make change less adversarial.
IFS and trauma therapy
This is where I find IFS particularly useful clinically.
Trauma processing is not always difficult because the memory itself is inaccessible.
Sometimes the problem is that part of the person does not feel safe approaching it.
One part says:
“I want this gone.”
Another says:
“If we open that door, everything will fall apart.”
That second part should not simply be overridden.
It may have spent years keeping the person functional.
IFS gives clinicians a way to work with that conflict before pushing into trauma processing.
IFS before ART or EMDR
Parts work can sometimes be useful before ART or EMDR.
For example:
A client wants to process a traumatic event.
But a protective part becomes highly anxious whenever the memory is approached.
Instead of assuming:
“The client is resistant,”
we can ask:
What is the protector afraid will happen?
What does it need?
Does it trust the process?
Is the target actually the right target?
That can improve pacing.
IFS during complex trauma treatment
Complex trauma often involves multiple competing internal needs.
One part wants closeness.
Another fears it.
One wants independence.
Another desperately wants care.
One wants to confront someone.
Another wants to disappear.
That complexity can make parts language especially useful.
It provides a framework for holding contradictions without forcing premature resolution.
What about IFS and dissociation?
This requires nuance.
Parts language can be extremely useful with dissociative experiences.
But significant dissociation also requires specialized assessment and clinical judgment.
IFS should not be used as a substitute for assessing dissociative disorders or determining whether someone is stable enough for trauma processing.
Not every experience of internal parts is dissociation.
And not every dissociative presentation should be treated casually because parts language feels familiar.
What about IFS and self-compassion?
Self-compassion is one of the outcomes that appears repeatedly in emerging IFS research.
For example, the rheumatoid arthritis trial found sustained improvement in self-compassion at follow-up.
The PARTS PTSD research has also examined processes including self-compassion, decentering, and emotion regulation.
That makes conceptual sense.
A therapy built around approaching protective reactions with curiosity rather than hostility would reasonably be expected to affect how people relate to themselves.
The mechanism still needs more research.
Does IFS “heal the nervous system”?
That phrase gets used broadly online.
It is not a precise scientific claim.
IFS may reduce distress.
It may change emotional responses.
It may affect regulation.
Any successful psychotherapy can influence brain and nervous-system functioning.
But we do not currently have enough mechanistic neuroscience research to make strong IFS-specific claims about “rewiring” or “resetting” the nervous system.
Does IFS heal trauma stored in the body?
Again, this language goes farther than the evidence.
Trauma affects:
memory,
emotion,
physiology,
attention,
behavior,
relationships,
and bodily responses.
IFS may help clients relate differently to those experiences.
But trauma is not literally a substance trapped inside body tissue waiting for a part to release it.
Metaphor can be useful.
It should not be confused with mechanism.
Does IFS need neuroscience to be legitimate?
No.
This matters.
A therapy does not become credible because someone puts a brain diagram next to it.
The relevant scientific questions are:
Do clients improve?
Compared with what?
For which problems?
How large is the effect?
Does it last?
Who benefits?
Who does not?
What mechanisms mediate change?
Those are better questions than whether a therapy sounds neuroscientific.
What research does IFS need next?
The field needs:
larger randomized trials,
independent replication,
well-matched active control groups,
condition-specific studies,
longer follow-up,
and research identifying which components are actually responsible for change.
For PTSD specifically, additional trials need to determine whether IFS-based interventions outperform credible comparison treatments—not only whether symptoms improve during treatment.
Why independent replication matters
Some early therapy research is conducted by researchers closely connected to the treatment model.
That is common in psychotherapy development.
Developers and early adopters are often the people motivated enough to study a new approach.
But as the evidence base grows, independent replication becomes increasingly important.
A treatment becomes much more scientifically convincing when researchers without a strong allegiance to the model repeatedly find similar effects.
Can a therapy be clinically useful before the research is complete?
Absolutely.
Clinical practice always involves working with imperfect information.
The important thing is matching confidence to evidence.
A therapist can say:
“I find IFS clinically useful for understanding protective patterns.”
That is different from saying:
“Research has proven IFS is one of the most effective trauma treatments.”
The first statement can be clinically grounded.
The second currently goes beyond the evidence.
How I use IFS
I trained in Internal Family Systems through the IFS Institute and use parts work as one component of a broader treatment approach.
I am especially interested in IFS when a client seems caught between opposing needs or when protective reactions interfere with trauma processing.
For example:
“I want to process this memory, but part of me absolutely does not.”
“I want intimacy, but I panic when someone gets close.”
“I know this was not my fault, but some part of me still feels ashamed.”
“I want to stop controlling everything, but control is the only thing that feels safe.”
Parts work can help us understand what those responses are doing before trying to change them.
IFS alongside ART and EMDR
I do not think these approaches have to compete.
IFS can help us understand:
who is afraid,
who is protecting,
what the system believes will happen,
and whether there is enough permission to proceed.
ART or EMDR may then be useful for processing a specific memory or target.
Sometimes the most important intervention is not another processing set.
It is understanding why part of the person believes processing itself is dangerous.
IFS within therapy intensives
Parts work can also be particularly useful in intensive therapy.
A longer session gives more room to:
identify protectors,
understand internal conflict,
prepare for focused memory work,
pause when needed,
and integrate what happened afterward.
An intensive does not have to mean hours of continuous ART or EMDR.
IFS can help create structure around when processing makes sense—and when it does not.
So what does the research say about IFS?
At this point, the fairest answer is:
IFS has a growing but still limited evidence base.
Small randomized studies have reported promising findings for depression and psychological outcomes in chronic illness.
Early PTSD studies suggest an IFS-based group program is feasible and acceptable.
A 2026 randomized PTSD trial found significant improvement in both IFS-based treatment and an active comparison group, but did not find a significant difference between them on PTSD symptom reduction.
The IFS Institute itself acknowledges that the evidence remains limited and calls for larger replicated randomized studies.
That is promising science.
It is not yet a mature evidence base.
And that distinction is important
We do not need to inflate IFS to appreciate it.
IFS can be clinically compelling.
Clients often connect strongly with its language.
It can offer a humane way to understand internal conflict.
It can integrate beautifully with other trauma therapies.
And researchers are increasingly studying it.
Those are meaningful reasons to pay attention.
They are also enough.
We do not need to turn emerging evidence into certainty before the science gets there.
Working with Laura Geftman, LCSW
I use Internal Family Systems alongside Accelerated Resolution Therapy, EMDR, Cognitive Processing Therapy, Prolonged Exposure, CBT, psychodynamic, interpersonal, attachment, and schema therapies depending on the client and clinical question.
I completed IFS training through the Internal Family Systems Institute and use parts work particularly when protective responses, internal conflict, shame, or fear complicate trauma processing.
I offer focused therapy and therapy intensives for adults in Pennsylvania, New Jersey, New York, and Florida.
In-person therapy intensives are available in Ardmore, PA, on the Main Line near Philadelphia.
Virtual therapy may also be available when clinically appropriate.
Interested in IFS, ART, EMDR, or focused trauma therapy?
You do not need to choose a therapy based on which modality has the most compelling explanation.
The more useful question is what is happening for you.
Is there a specific memory?
A protective pattern?
An internal conflict?
A body response?
A trigger?
A part of you that wants change while another part is terrified of it?
An initial consultation can help determine what kind of work makes sense.
Suggested Reading
If you are interested in IFS, trauma processing, ART, EMDR, or therapy intensives, these related articles may be helpful:
Can ART Be Used Adjunctively While a Client Stays With Their Primary Therapist?
Can Trauma Therapy Help With a Memory I Can’t Stop Replaying?
FAQ
Is Internal Family Systems therapy evidence-based?
IFS has an emerging empirical evidence base, including randomized trials, but the research remains much smaller than the evidence bases for treatments such as EMDR, CPT, and Prolonged Exposure. The IFS Institute itself states that more replicated randomized research is needed.
Is there research on IFS for PTSD?
Yes. Early studies of the IFS-based PARTS program have examined PTSD. A 2026 randomized controlled trial found significant PTSD symptom improvement in both PARTS and an active comparison treatment, but no statistically significant difference between the two groups on the primary PTSD outcome.
Has IFS been studied for depression?
Yes. A randomized pilot involving 37 female college students found depressive symptoms decreased in both IFS and treatment-as-usual groups, with no significant difference in the magnitude or rate of improvement between conditions.
Has IFS been studied for physical health conditions?
Yes. A randomized proof-of-concept trial in rheumatoid arthritis found improvements in some outcomes including pain, physical function, self-compassion, and depressive symptoms, while objective disease activity did not show sustained improvement.
Is IFS a first-line PTSD treatment?
IFS does not currently have the same depth of PTSD evidence as established trauma-focused treatments such as EMDR, CPT, and Prolonged Exposure. Its PTSD evidence is emerging rather than mature.
Does IFS treat “parts” because having parts means someone is dissociative?
No. IFS views internal multiplicity as normal. People commonly experience conflicting motivations or internal states without having a dissociative disorder.
Can IFS help before EMDR or ART?
It may be clinically useful when protective parts are fearful of trauma processing, when there is strong internal conflict, or when more preparation is needed before approaching a target.
Can IFS be combined with ART or EMDR?
Yes, clinicians trained in these approaches may integrate parts work with trauma processing. The purpose is not to blend modalities indiscriminately but to use each intervention for a clear clinical reason.
Does IFS rewire the nervous system?
That is not an established IFS-specific scientific mechanism. Effective psychotherapy can influence emotional and neural functioning, but claims that IFS specifically “resets” or “rewires” the nervous system go beyond the current evidence.
Is the research on IFS promising?
Yes. There are encouraging randomized and feasibility studies, including newer PTSD research. But larger independent trials and replication are still needed before strong condition-specific efficacy claims can be made.